← Open Payments lookup

MONISSA SOLBERG: Open Payments

NPI 1164658027 · RIVERSIDE, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,455 in 127 payments from 15 companies in 2025. Trend: 2023 $3,131 · 2024 $2,981 · 2025 $2,455

Food & beverage: $2,336Education: $119
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.9$286
Takeda Pharmaceuticals U.S.A., Inc.19$265
Neurocrine BioSciences, Inc.16$261
Axsome Therapeutics, Inc.12$247
Vanda Pharmaceuticals Inc.8$220
E.R. Squibb & Sons, L.L.C.12$210
Alkermes, Inc.11$205
Supernus Pharmaceuticals, Inc.12$172
Collegium Pharmaceutical, Inc.9$156
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$123

Products named: TRINTELLIX, INGREZZA, Auvelity, FANAPT, COBENFY, AUSTEDO XR, REXULTI, Qelbree.

Industry payments across RI — which companies pay providers there.